| Emily Drummond, DO | |
|
1010 Spruce St, Espanola, NM 87532-2724 | |
| (505) 753-7111 | |
| Not Available |
| Full Name | Emily Drummond |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 15 Years |
| Location | 1010 Spruce St, Espanola, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003143918 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 58.003350 (Ohio) | Secondary |
| 207P00000X | Emergency Medicine | 34.010921 (Ohio) | Secondary |
| 207P00000X | Emergency Medicine | A-1944-16 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Presbyterian Espanola Hospital | Espanola, NM | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Presbyterian Healthcare Services | 9234041708 | 1099 |
News Archive
For the first time, scientists have replicated hepatitis C virus (HCV) in the laboratory. The ability to replicate HCV in cell culture will allow researchers to better study the life cycle and biology of this virus and to test potential antiviral compounds, which may lead to new therapies for the liver disease that results from infection with HCV.
Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).
Research published in the February edition of the Journal of Thoracic Oncology sought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen's two-week break has on survival outcomes.
A study published in the current issue of the Canadian Medical Association Journal (CMAJ) by Dhalla et al. has reviewed opioid-related deaths in Ontario from 1991 to 2004. The Canadian Pain Society (CPS) is very concerned that a small percentage of the population is misusing opioid analgesics, also called narcotic pain killers, resulting in harm and even death.
More than £6M of funding has been awarded to enhance the development of biopharmaceuticals. In total £6.5M will fund 12 projects to deliver commercially important results, such as industrial-scale production of antibodies, stem cell preservation at room temperature, biopharmaceutical production using microbes and commercial scale stem cell therapy.
› Verified 8 days ago
| Entity Name | Presbyterian Healthcare Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104802354 PECOS PAC ID: 9234041708 Enrollment ID: O20031103000603 |
News Archive
For the first time, scientists have replicated hepatitis C virus (HCV) in the laboratory. The ability to replicate HCV in cell culture will allow researchers to better study the life cycle and biology of this virus and to test potential antiviral compounds, which may lead to new therapies for the liver disease that results from infection with HCV.
Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).
Research published in the February edition of the Journal of Thoracic Oncology sought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen's two-week break has on survival outcomes.
A study published in the current issue of the Canadian Medical Association Journal (CMAJ) by Dhalla et al. has reviewed opioid-related deaths in Ontario from 1991 to 2004. The Canadian Pain Society (CPS) is very concerned that a small percentage of the population is misusing opioid analgesics, also called narcotic pain killers, resulting in harm and even death.
More than £6M of funding has been awarded to enhance the development of biopharmaceuticals. In total £6.5M will fund 12 projects to deliver commercially important results, such as industrial-scale production of antibodies, stem cell preservation at room temperature, biopharmaceutical production using microbes and commercial scale stem cell therapy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Drummond, DO Po Box 26666, Phs Provider Enrollment, Albuquerque, NM 87125-6666 Ph: (505) 923-6770 | Emily Drummond, DO 1010 Spruce St, Espanola, NM 87532-2724 Ph: (505) 753-7111 |
News Archive
For the first time, scientists have replicated hepatitis C virus (HCV) in the laboratory. The ability to replicate HCV in cell culture will allow researchers to better study the life cycle and biology of this virus and to test potential antiviral compounds, which may lead to new therapies for the liver disease that results from infection with HCV.
Aradigm Corporation today announced that Zogenix, Inc. and Desitin Pharmaceuticals GmbH were granted approval of the Marketing Authorization Application for SUMAVEL® DosePro™ (sumatriptan injection) needle-free delivery system for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache by the Federal Institute for Drugs and Medical Devices of Germany (BrArM) and the Medicines and Healthcare products Regulatory Agency of the United Kingdom (MHRA).
Research published in the February edition of the Journal of Thoracic Oncology sought to assess the overall efficacy of split-course palliative chest radiotherapy (RT) for symptom relief in patients with advanced non-small cell lung cancer. Additionally, researchers investigated the impact the regimen's two-week break has on survival outcomes.
A study published in the current issue of the Canadian Medical Association Journal (CMAJ) by Dhalla et al. has reviewed opioid-related deaths in Ontario from 1991 to 2004. The Canadian Pain Society (CPS) is very concerned that a small percentage of the population is misusing opioid analgesics, also called narcotic pain killers, resulting in harm and even death.
More than £6M of funding has been awarded to enhance the development of biopharmaceuticals. In total £6.5M will fund 12 projects to deliver commercially important results, such as industrial-scale production of antibodies, stem cell preservation at room temperature, biopharmaceutical production using microbes and commercial scale stem cell therapy.
› Verified 8 days ago
Karen G Connaughton, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-753-7111 Fax: 505-753-4438 | |
Fernando Bayardo, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-367-0340 Fax: 505-367-0346 | |
Patrick Montoya, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-367-0340 Fax: 505-367-0346 | |
Lea Pazos Creekmur O'dell, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-753-7111 | |
Valerie Merl, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola Hospital, Espanola, NM 87532 Phone: 505-753-7111 Fax: 505-753-4438 | |
Dr. Gary Kanner, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-753-7111 | |
Dr. Brandon Allen Quinn, MD, MPH Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1010 Spruce St, Espanola, NM 87532 Phone: 505-753-1553 |